Tag: Gene Editing
-
First-in-Human Gene-Editing Therapy Halves Bad Cholesterol: CTX310 Trial Signals Breakthrough
Groundbreaking CTX310 Trial in Australia Shows Promise for Hard-to-Treat Lipid Disorders In a landmark study conducted in Australia, researchers have reported that a first-in-human trial of CTX310—a gene-editing therapy—effectively halves levels of low-density lipoprotein (LDL) cholesterol and triglycerides in individuals with lipid disorders that are difficult to manage with current treatments. The early results, unveiled…
-
Time gene editing therapy to halve bad cholesterol: Australia leads first-in-human trial
Groundbreaking first-in-human trial unfolds in Australia Researchers in Melbourne have announced a landmark first-in-human trial of a gene-editing therapy aimed at drastically reducing harmful lipids in the blood. The study tests CTX310, a pioneering treatment designed for people with difficult-to-treat lipid disorders who struggle to control their LDL cholesterol and triglyceride levels despite standard therapies.…
-
CRISPR Gene-Editing Shows Promise in Lowering Cholesterol in Early Study
New CRISPR-based therapy reduces cholesterol in a small early study A recent small-stage study has sparked cautious optimism in the fight against high cholesterol. Researchers tested an experimental gene-editing therapy delivered by a single infusion to participants with elevated cholesterol levels. The approach uses CRISPR gene editing to target and alter the body’s pathways that…
-
CRISPR Gene Editing Shows Promise in Lowering Cholesterol in Initial Study
CRISPR Gene Editing: A Bold Step in Cholesterol Management Scientists are exploring a groundbreaking approach to fighting high cholesterol using CRISPR gene-editing technology. In a small, early clinical trial, researchers administered a single infusion of an experimental gene-editing drug to a group of volunteers with elevated cholesterol. The results offered a glimmer of hope that…
-
Scientists Edge Closer to Reversing Memory Loss in Aging Brains
New Hope in the Fight Against Memory Decline Researchers are reporting promising progress in the quest to reverse memory loss associated with aging. Two complementary studies led by Timothy Jarome, an associate professor in the College of Agriculture and Life Sciences’ School of Animal Sciences, and his team used cutting-edge gene-editing tools to address molecular…
-
Scientists Reveal Potential to Reverse Memory Loss in Aging Brains
Groundbreaking studies point to reversing memory loss Researchers are reporting promising advances in addressing memory decline that often accompanies aging. In two complementary studies, a team led by associate professor Timothy Jarome and his graduate students employed advanced gene-editing tools to target molecular changes linked to memory formation and retention. The work aims to understand…
-
Scientists Edge Toward Reversing Memory Loss in Aging Brains with Gene Editing
New Frontiers in Memory and Aging Scientists are moving closer to a breakthrough in how aging brains can regain memory function. In two complementary studies led by Timothy Jarome, associate professor in the College of Agriculture and Life Sciences’ School of Animal Sciences, researchers used advanced gene-editing tools to target molecular changes associated with memory…
-
Pig Liver Breakthrough: Genetically Engineered Organ Sustains Human Metabolism for 31 Days
Overview of a Historic Transplant In a landmark medical achievement, doctors have transplanted a genetically engineered pig liver into a living human for the first time. The procedure, conducted to explore the viability of xenotransplantation (animal-to-human organ transfer), demonstrated that a pig liver can function and support essential metabolic processes in a human body for…
-
Pig Liver Breakthrough: Genetically Modified Organ Functions in Human for 31 Days
Groundbreaking Xenotransplantation Milestone In a historic medical achievement, doctors transplanted a genetically engineered pig liver into a living human for the first time. The modified organ operated alongside the patient’s own liver, providing essential metabolic support for more than 31 days. Published findings in the Journal of Hepatology detail how the liver began functioning immediately,…
-
Advancing Gene Editing: How Lipid Nanoparticles Are Shaping CRISPR Delivery
Introduction: The delivery bottleneck in CRISPR therapies CRISPR-based medicines hold the promise of treating a wide range of diseases, but their success hinges on effective delivery. Early efforts relied on viral vectors, especially adeno-associated viruses (AAVs), to ferry genetic material. While AAVs can deliver DNA, their payload size is limited and пациентов often develop immune…